-
Cusumano P, Generali D, Ciruelos E, Manso L, Ghanem I, Lifrange E, Jerusalem G, Klaase J, de Snoo F, Stork-Sloots L, Dekker-Vroling L, Lutke Holzik M. European inter-institutional impact study of MammaPrint. Breast (Edinburgh, Scotland), 03/2014; 23(4).
-
Metzger-Filho O, Catteau A, Michiels S, Buyse M, Ignatiadis M, Saini K S, de Azambuja E, Fasolo V, Naji S, Canon JL, [...], Kains JP, Larsimont D, Richard V, Faverly D, Cornez N, Vuylsteke P, Vanderschueren B, Peyro-Saint-Paul H, Piccart M, Sotiriou Ch. Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer. PLoS ONE 08/2013; 8(8):e66848.
-
Nguyen B, Cusumano P G, Deck K, Kerlin D, Garcia A A, Barone J, Rivera E, Yao K, de Snoo F, van den Akker J, Stork-Sloots L, Generali D. Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients. Annals of Surgical Oncology 10/2012; 19(10):3257-63.
-
Cusumano P, Gomez P, Dwelshauvers J, Lilet H, Nos C. Prospective Evaluation of Pre and Postoperative Lymphoscintigraphy in Axillary Reverse Mapping (ARM) for Breast Cancer Patients. Cancer Research 02/2010; 69(24 Supplement):1025-1025.
-
Nos C, Kaufmann G, Clough K B, Collignon MA, Zerbib E, Cusumano P, Lecuru F. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Annals of Surgical Oncology 07/2008; 15(9):2550-5.